Report overview
Submucosal Tissue Lifting Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
This report contains market size and forecasts of Submucosal Tissue Lifting Agent in global, including the following market information:
Global Submucosal Tissue Lifting Agent Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Submucosal Tissue Lifting Agent Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Submucosal Tissue Lifting Agent companies in 2022 (%)
The global Submucosal Tissue Lifting Agent market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Prefilled Syringe Type Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Submucosal Tissue Lifting Agent include Seikagaku, Ovesco Endoscopy, Boston Scientific, The Standard, GI Supply, Cosmo Pharmaceuticals, Micro-Tech Endoscopy and EndoClot Plus, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Submucosal Tissue Lifting Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Submucosal Tissue Lifting Agent Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Submucosal Tissue Lifting Agent Market Segment Percentages, by Type, 2022 (%)
Prefilled Syringe Type
Ampoule Type
Global Submucosal Tissue Lifting Agent Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Submucosal Tissue Lifting Agent Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Submucosal Tissue Lifting Agent Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Submucosal Tissue Lifting Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Submucosal Tissue Lifting Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Submucosal Tissue Lifting Agent revenues share in global market, 2022 (%)
Key companies Submucosal Tissue Lifting Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Submucosal Tissue Lifting Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Seikagaku
Ovesco Endoscopy
Boston Scientific
The Standard
GI Supply
Cosmo Pharmaceuticals
Micro-Tech Endoscopy
EndoClot Plus
